COVID-19: US FDA’s Hahn Slams The Brakes On Domestic Inspections ‘For The Health And Well-Being Of Our Staff’

“I want to assure the American public that we have full confidence in the safety and quality of the products we all use every day,” agency head Stephen Hahn says

A little more than a month after it put the kibosh on conducting facility inspections in China, the agency announced late on 18 March that it was suspending routine surveillance audits in the US, too.

Coronavirus_2019nCov

More from Regulation

More from Policy & Regulation